The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism / Q000627:therapeutic use*; D000328:Adult; D000450:Aldosterone / Q000097:blood / Q000378:metabolism*; D001835:Body Weight / Q000187:drug effects; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000652:urine; D011279:Pregnanetriol / Q000652:urine; D011863:Radioimmunoassay; D012636:Secretory Rate / Q000187:drug effects; D013268:Stimulation, Chemical; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D014316:Tritium; D011279:Pregnanetriol; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone; D011188:Potassium; D006854:Hydrocortisone